Karrieretipps & Hinweise
Abschnitte
-
What Does a Clinical SAS Programmer Do?
16.04.2024
Within the realm of clinical research, a Statistical Analysis System (SAS) Programmer is responsible for managing, analysing, and interpreting clinical data utilising SAS software. This includes developing and applying statistical techniques to assess the efficacy, safety, and value of a pharmace... -
Roche’s Columvi meets primary endpoint of overall survival in people with relapsed or refractory ...
16.04.2024
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the Phase III STARGLO study met its primary endpoint of overall survival. -
Roche granted FDA Breakthrough Device Designation for blood test to support earlier Alzheimer's d...
11.04.2024
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that its Elecsys pTau217 assay received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA). -
In this recruiter guide, we explore the essential considerations for you to keep in mind when hiring a Biostatistician. From understanding the unique demands of the role to identifying key competencies and conducting effective interviews, this guide will help you to focus your candidate search an...
-
Clinical Research Employers in Europe
11.04.2024
An up to date list of Employers in Europe, hiring for clinical research positions right now. -
The Evolution of Clinical Data Management
10.04.2024
Clinical Data Management (CDM) has drastically transformed over the years, proactively adapting to technological advancements, changing regulations, and the growing complexity of clinical trials. -
9 Clinical Data Management Career Paths
08.04.2024
As the life science industry becomes increasingly data-driven, the field of clinical data management (CDM) is expanding, offering a wealth of career opportunities for those interested in leveraging data to improve patient outcomes and healthcare processes. -
Results announced from EMPACT-MI phase III trial investigating the effect of Jardiance® (empaglif...
08.04.2024
The EMPACT-MI phase III clinical trial showed a 10% relative risk reduction in the primary composite endpoint of time to first hospitalization due to heart failure or all-cause mortality for empagliflozin versus placebo, which did not reach statistical significance. -
From understanding the unique demands of the role to identifying key competencies and conducting effective interviews, this guide will provide you with valuable tips to help you focus your candidate search and engage top talent.
-
Artificial Intelligence and Machine Learning in Clinical Data Management: Opportunities and Ethic...
04.04.2024
Artificial Intelligence (AI) and Machine Learning (ML) promise to revolutionise how clinical data is collected, analysed, and utilised, offering unprecedented opportunities for enhancing trial efficiency and patient outcomes. -
A Clinical Research Coordinator (CRC) is a specialised research professional who works under the direction of a Clinical Principal Investigator (PI). They play an important role in conducting and managing clinical trials, providing outcomes that shape medical advances in areas such as preventativ...
-
About Oncopeptides
03.04.2024
Oncopeptides is a biotech company focusing on research, development and commercialization of targeted therapies for difficult-to-treat cancers. The company uses its proprietary Peptide Drug Candidate platform (PDC) to develop compounds that rapidly and selectively deliver cytotoxic agents into ca... -
About Heidelberg Pharma
28.03.2024
Heidelberg Pharma is an oncology specialist and the first company to develop the toxin Amanitin into cancer therapies using its proprietary ATAC technology and to advance the biological mode of action of the toxin as a novel therapeutic principle. -
About Laverock Therapeutics
26.03.2024
Laverock Therapeutics is a gene-silencing company with a uniquely powerful technology which harnesses the cell’s natural gene regulatory mechanisms to develop a new generation of programmable advanced therapies to tackle major diseases. -
Laverock Therapeutics announces appointment of Ali Elsley as Finance Director and expansion of team
26.03.2024
Laverock Therapeutics, a gene-silencing company with a uniquely powerful technology for the development of programmable advanced therapies to tackle major diseases, today announces the appointment of Ali Elsley as Finance Director. -
Cambridge Cognition Holdings plc (AIM: COG), which develops and markets digital solutions to assess brain health, is pleased to announce the formation of a Scientific Advisory Board.
-
Employees from top biopharma companies such as AbbVie, AXON and Aspire Scientific are amongst the 250,000 UK personnel who surveyed with Great Place To Work® UK. Using the data gathered from the research-backed and anonymous employee experience surveys, Great Place To Work has announced its annu...
-
About Cambridge Cognition
21.03.2024
Cambridge Cognition is a technology company developing digital health products to better understand, detect and treat conditions affecting brain health. -
Bayer and Thermo Fisher Scientific collaborate to increase patient access to precision cancer med...
20.03.2024
Bayer AG and Thermo Fisher Scientific Inc. today announced to develop next-generation sequencing (NGS)-based companion diagnostic assays (CDx) together. -
Charac, a leading healthcare SaaS provider, today announces the acquisition of Pro Delivery Manager (PDM), a leading prescription delivery management system, from its shareholders, which include the National Pharmacy Association (NPA).